Here's How This Forgotten Healthcare Stock Could Generate LifeChanging Returns Prosper Junior Bakiny, The Motley FoolAugust 17, 2025 at 11:41 PM Key Points CRISPR Therapeutics' first approved therapy, Casgevy, was a breakthrough.
Not All Advisors Are Equal — Here's the Real Difference Between Fiduciary and Financial Advisors
Not All Advisors Are Equal — Here's the Real Difference Between Fiduciary and Financial Advisors AJ FabinoAugust 17, 2025 at 11:41 PM If you've ever thought about hiring someone to help manage your money, you've probably run into a tangle of titles: financial advisor, financial planner, wealth strat...
2 Great Dividend Stocks for the Long Haul You'll Likely Wish You Bought 10 Years From Now
2 Great Dividend Stocks for the Long Haul You'll Likely Wish You Bought 10 Years From Now Daniel Sparks, The Motley FoolAugust 17, 2025 at 11:50 PM Key Points Tractor Supply delivers a modest but wellsupported dividend backed by a resilient rural retail niche.
The Most Important Thing for Advance Auto Parts Investors to Watch in 2025
The Most Important Thing for Advance Auto Parts Investors to Watch in 2025 Lee Samaha, The Motley FoolAugust 17, 2025 at 11:59 PM Key Points Advanced Auto Part's restructuring has returned the company to profitability, and it should start generating cash in the second half.
Is Palantir the Next Tesla?
Is Palantir the Next Tesla? Keithen Drury, The Motley FoolAugust 18, 2025 at 12:00 AM Key Points Tesla is a popular stock among individual investors. Palantir also doesn't have much institutional ownership.
